Granahan Investment Management, LLC Repligen Corp Transaction History

Granahan Investment Management, LLC

  • $2.38 Billion
  • Q3 2024

A detailed history of Granahan Investment Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Granahan Investment Management, LLC holds 88,255 shares of RGEN stock, worth $13 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
88,255
Holding current value
$13 Million
% of portfolio
0.55%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$119.79 - $167.35 $10.6 Million - $14.8 Million
88,255 New
88,255 $13.1 Million
Q1 2024

May 15, 2024
SELL
$170.78 - $208.42 $840,408 - $1.03 Million
-4,921 Reduced 3.79%
124,765 $22.9 Million
Q4 2023

Feb 14, 2024
SELL
$114.17 - $185.35 $350,730 - $569,395
-3,072 Reduced 2.31%
129,686 $23.3 Million
Q3 2023

Nov 14, 2023
SELL
$138.78 - $176.51 $2.5 Million - $3.18 Million
-18,014 Reduced 11.95%
132,758 $21.1 Million
Q2 2023

Aug 14, 2023
BUY
$138.42 - $180.31 $5.49 Million - $7.15 Million
39,632 Added 35.66%
150,772 $21.3 Million
Q1 2023

May 15, 2023
BUY
$154.26 - $198.1 $535,899 - $688,199
3,474 Added 3.23%
111,140 $18.7 Million
Q4 2022

Feb 14, 2023
BUY
$162.42 - $220.56 $6.55 Million - $8.9 Million
40,344 Added 59.93%
107,666 $18.2 Million
Q3 2022

Nov 14, 2022
SELL
$160.42 - $256.21 $9 Million - $14.4 Million
-56,100 Reduced 45.45%
67,322 $12.6 Million
Q2 2022

Aug 15, 2022
BUY
$140.68 - $188.02 $14.1 Million - $18.8 Million
99,947 Added 425.76%
123,422 $20 Million
Q1 2022

May 16, 2022
BUY
$161.19 - $257.96 $3.78 Million - $6.06 Million
23,475 New
23,475 $4.42 Million
Q3 2021

Nov 15, 2021
SELL
$194.77 - $324.21 $774,405 - $1.29 Million
-3,976 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$165.87 - $220.95 $5.4 Million - $7.19 Million
-32,552 Reduced 89.12%
3,976 $794,000
Q1 2021

May 17, 2021
BUY
$180.37 - $226.26 $1.78 Million - $2.23 Million
9,847 Added 36.91%
36,528 $7.1 Million
Q4 2020

Feb 12, 2021
SELL
$148.08 - $206.57 $15.3 Million - $21.3 Million
-103,269 Reduced 79.47%
26,681 $5.11 Million
Q3 2020

Nov 12, 2020
SELL
$122.51 - $158.27 $4.57 Million - $5.9 Million
-37,281 Reduced 22.29%
129,950 $19.2 Million
Q2 2020

Aug 14, 2020
SELL
$94.33 - $140.48 $3.38 Million - $5.04 Million
-35,883 Reduced 17.67%
167,231 $21.3 Million
Q1 2020

May 12, 2020
SELL
$84.96 - $109.14 $3.28 Million - $4.21 Million
-38,552 Reduced 15.95%
203,114 $19.6 Million
Q4 2019

Feb 14, 2020
SELL
$73.84 - $93.08 $75,464 - $95,127
-1,022 Reduced 0.42%
241,666 $22.4 Million
Q3 2019

Nov 15, 2019
SELL
$76.65 - $95.51 $1 Million - $1.25 Million
-13,067 Reduced 5.11%
242,688 $18.6 Million
Q2 2019

Aug 14, 2019
SELL
$54.2 - $85.95 $1.19 Million - $1.89 Million
-22,041 Reduced 7.93%
255,755 $22 Million
Q1 2019

May 14, 2019
BUY
$49.45 - $62.8 $593,103 - $753,223
11,994 Added 4.51%
277,796 $16.4 Million
Q4 2018

Feb 13, 2019
SELL
$48.26 - $68.88 $73,065 - $104,284
-1,514 Reduced 0.57%
265,802 $14 Million
Q3 2018

Nov 13, 2018
BUY
$46.8 - $58.97 $4.17 Million - $5.26 Million
89,157 Added 50.04%
267,316 $14.8 Million
Q2 2018

Aug 15, 2018
BUY
$35.26 - $47.04 $678,049 - $904,579
19,230 Added 12.1%
178,159 $8.38 Million
Q1 2018

May 14, 2018
BUY
$30.92 - $37.27 $4 Million - $4.82 Million
129,230 Added 435.13%
158,929 $5.75 Million
Q4 2017

Feb 12, 2018
BUY
$32.53 - $38.92 $966,108 - $1.16 Million
29,699
29,699 $1.08 Million

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email